<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Arylamine metabolism" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Simplified scheme of arylamine metabolism pathway. Arylamines are N-acetylated by NAT2 in the liver, transforming them to relatively nonreactive. Alternatively, they may be N-hydroxylated by CYPIA2, trans - ported to the bladder, and undergo O-acetylation by NATI, to form a highly reactive species. [https://www.researchgate.net/figure/Simplified-scheme-of-arylamine-metabolism-pathway-Arylamines-are-N-acetylated-by-NAT2-in_fig2_288003735]</Comment>
  <Comment Source="WikiPathways-category">Metabolic Process</Comment>
  <BiopaxRef>c34</BiopaxRef>
  <Graphics BoardWidth="659.20558759907" BoardHeight="626.0"/>
  <DataNode TextLabel="UGT1A9" GraphId="a042b" Type="GeneProduct" GroupRef="cfd1a">
        </DataNode>
  <DataNode TextLabel="UGT1A4" GraphId="a1f59" Type="GeneProduct" GroupRef="cfd1a">
        </DataNode>
  <DataNode TextLabel="CYP1A2" GraphId="bb0f4" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="NAT1" GraphId="c0e47" Type="GeneProduct" GroupRef="ea6b4">
        </DataNode>
  <DataNode TextLabel="SULT1A2" GraphId="c3d82" Type="GeneProduct" GroupRef="af4e1">
        </DataNode>
  <DataNode TextLabel="NAT1" GraphId="c541c" Type="GeneProduct" GroupRef="ea9b3">
        </DataNode>
  <DataNode TextLabel="N-Acetylarylamine" GraphId="cbb69" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="O-acetylarylamine" GraphId="d06f5" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="N-aryl sulfamic acid" GraphId="d0f9e" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Deacetylase" GraphId="d1bbc" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="NAT2" GraphId="d55e5" Type="GeneProduct" GroupRef="ea9b3">
        </DataNode>
  <DataNode TextLabel="Acetyl-CoA" GraphId="d5a3e" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="SULT1A1" GraphId="d94ce" Type="GeneProduct" GroupRef="af4e1">
        </DataNode>
  <DataNode TextLabel="Arylamine" GraphId="e147e" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="an N-hydroxyarylamine" GraphId="e55d1" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Arylamine N-glucuronide" GraphId="ebb60" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="N-hydroxy-N-acetylamine" GraphId="f2ba4" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Coenzyme A" GraphId="f2bcc" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Arylamine N,O-sulfate" GraphId="f7f51" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Deacetylase" GraphId="f9488" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="NAT2" GraphId="fc98b" Type="GeneProduct" GroupRef="ea6b4">
        </DataNode>
  <Interaction GraphId="a5212">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="cbb69"/>
      <Point GraphRef="e147e" ArrowHead="Arrow"/>
      <Anchor Position="0.5076073151079956" Shape="None" GraphId="bb468"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aa81f">
    <BiopaxRef>ba8</BiopaxRef>
    <Graphics>
      <Point GraphRef="e147e"/>
      <Point GraphRef="e55d1" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5436893203883495" Shape="None" GraphId="a4319"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ac2d4">
    <Graphics>
      <Point GraphRef="b7000"/>
      <Point GraphRef="aad4e" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="be768">
    <Graphics>
      <Point GraphRef="bb0f4"/>
      <Point GraphRef="c77fd" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c4a29">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e147e"/>
      <Point GraphRef="d0f9e" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c7852">
    <Graphics>
      <Point GraphRef="e147e"/>
      <Point GraphRef="ebb60" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4603174603174603" Shape="None" GraphId="a0afc"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c9255">
    <BiopaxRef>ba8</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e147e"/>
      <Point GraphRef="cbb69" ArrowHead="Arrow"/>
      <Anchor Position="0.4748917665490336" Shape="None" GraphId="e2eb9"/>
      <Anchor Position="0.4766764268623647" Shape="None" GraphId="a36a4"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cc844">
    <Graphics>
      <Point GraphRef="bb0f4"/>
      <Point GraphRef="a4319" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d2c5c">
    <BiopaxRef>ba8</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="e55d1"/>
      <Point GraphRef="d06f5" ArrowHead="mim-conversion"/>
      <Anchor Position="0.24605729588741612" Shape="None" GraphId="f7c55"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d6849">
    <BiopaxRef>a13</BiopaxRef>
    <Graphics>
      <Point GraphRef="e55d1"/>
      <Point GraphRef="f7f51" ArrowHead="mim-conversion"/>
      <Anchor Position="0.47619047619047616" Shape="None" GraphId="d8c0f"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d9890">
    <Graphics>
      <Point GraphRef="c6a15"/>
      <Point GraphRef="e2eb9" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d9c79">
    <BiopaxRef>ba8</BiopaxRef>
    <Graphics>
      <Point GraphRef="cbb69"/>
      <Point GraphRef="f2ba4" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5323535781689923" Shape="None" GraphId="c77fd"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d9f02">
    <Graphics>
      <Point GraphRef="f9488"/>
      <Point GraphRef="c0470" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e2b93">
    <Graphics>
      <Point GraphRef="b6ddb"/>
      <Point GraphRef="d8c0f" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e2ba7">
    <BiopaxRef>ba8</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="d06f5"/>
      <Point GraphRef="f5dde" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eb018">
    <Graphics>
      <Point GraphRef="b7000"/>
      <Point GraphRef="f7c55" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="efcb8">
    <Graphics>
      <Point GraphRef="d1bbc"/>
      <Point GraphRef="bb468" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f2392">
    <BiopaxRef>ba8</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f2ba4"/>
      <Point GraphRef="d06f5" ArrowHead="mim-conversion"/>
      <Anchor Position="0.21928515838129406" Shape="None" GraphId="aad4e"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fcec7">
    <Graphics>
      <Point GraphRef="f035a"/>
      <Point GraphRef="a0afc" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fdeab">
    <Graphics>
      <Point GraphRef="f2ba4"/>
      <Point GraphRef="e55d1" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5063291139240507" Shape="None" GraphId="c0470"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id49484ed3">
    <Graphics>
      <Point GraphRef="d5a3e"/>
      <Point GraphRef="e2eb9"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idb81bc2b4">
    <Graphics>
      <Point GraphRef="e2eb9"/>
      <Point GraphRef="f2bcc" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Label TextLabel="N,O-Transacetylation" GraphId="aaf1e">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="O-acetylation" GraphId="d9a78">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="DNA adducts" GraphId="f5dde">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Group GroupId="af4e1" GraphId="b6ddb" Style="Complex"/>
  <Group GroupId="ea9b3" GraphId="b7000" Style="Complex"/>
  <Group GroupId="ea6b4" GraphId="c6a15" Style="Complex"/>
  <Group GroupId="cfd1a" GraphId="f035a" Style="Complex"/>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c34">
      <bp:ID >24467436</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.</bp:TITLE>
      <bp:SOURCE >Br J Pharmacol</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Sim E</bp:AUTHORS>
      <bp:AUTHORS >Abuhammad A</bp:AUTHORS>
      <bp:AUTHORS >Ryan A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ba8">
      <bp:ID >7889851</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Polymorphism of human acetyltransferases.</bp:TITLE>
      <bp:SOURCE >Environ Health Perspect</bp:SOURCE>
      <bp:YEAR >1994</bp:YEAR>
      <bp:AUTHORS >Meyer UA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >metabolic pathway of secondary metabolites</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000147</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a13">
      <bp:ID >7834621</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Chou HC</bp:AUTHORS>
      <bp:AUTHORS >Lang NP</bp:AUTHORS>
      <bp:AUTHORS >Kadlubar FF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >arylamine metabolic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0001232</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
  </Biopax>
</Pathway>